PatientsVille.com Logo

PatientsVille

Penfill Side Effects

Common Penfill Side Effects

The most commonly reported Penfill side effects (click to view or check a box to report):

Hypoglycaemia (35)
Intentional Overdose (13)
Suicide Attempt (13)
Blood Glucose Fluctuation (11)
Anti-insulin Antibody Increased (8)
Blood Glucose Increased (7)
Hypoglycaemic Coma (7)
Anti-insulin Antibody (6)
Hepatic Function Abnormal (5)
Alanine Aminotransferase Increased (5)
Aspartate Aminotransferase Increased (5)
Oedema (5)
White Blood Cell Count Decreased (5)
Vomiting (4)
Neutrophil Count Decreased (4)
Anaemia (4)
Gastric Ulcer (4)
Altered State Of Consciousness (4)
Blood Pressure Decreased (4)
Injection Site Reaction (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Penfill Side Effects Reported to FDA

The following Penfill reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Penfill on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Depression
on May 18, 2006 Male from JAPAN , 71 years of age, was treated with Penfill 30r (insulin Human, Insulin Human Injection, Isophane). Directly after, patient experienced the unwanted or unexpected Penfill side effects: depression. Penfill 30r (insulin Human, Insulin Human Injection, Isophane) dosage: N/A.
Associated medications used:
  • Depas (etizolam)
  • Magmitt (magnesium Oxide)
  • Merislon (betahistine Mesilate)
  • Pletal (50 Mg Milligram(s), Bid, Oral)
  • Mucodyne (carbocisteine)
  • Basen (voglibose)


Acanthosis Nigricans, Injection Site Reaction
Patient was taking Penfill R Chu. Patient felt the following Penfill side effects: acanthosis nigricans, injection site reaction on Nov 25, 2010 from JAPAN Additional patient health information: Male , 74 years of age, weighting 138.9 lb, was diagnosed with and. Penfill R Chu dosage: 36 U, Qd.
Multiple prescriptions taken:
  • Penfill N Chu (12 U, Qd)


Anti-insulin Antibody Increased, Condition Aggravated, Diabetic Ketoacidotic Hyperglycaemic Coma, Hyperglycaemia, Hypoglycaemia, Psychiatric Symptom
Adverse event was reported on Nov 17, 2010 by a Male taking Penfill 30r Chu (Dosage: Not Reported) was diagnosed with and. Location: JAPAN , 78 years of age, After Penfill was administered, patient encountered several Penfill side effects: anti-insulin antibody increased, condition aggravated, diabetic ketoacidotic hyperglycaemic coma, hyperglycaemia, hypoglycaemia, psychiatric symptom. Patient was hospitalized.

Acanthosis Nigricans, Injection Site Reaction
on Nov 18, 2010 Male from JAPAN , 74 years of age, was diagnosed with and was treated with Penfill R Chu. Directly after, patient experienced the unwanted or unexpected Penfill side effects: acanthosis nigricans, injection site reaction. Penfill R Chu dosage: 36 U, Qd.
Associated medications used:
  • Penfill N Chu (12 U, Qd)



Anti-insulin Antibody Increased, Hypoglycaemia Unawareness
on Nov 10, 2010 Female from JAPAN , 43 years of age, was diagnosed with and was treated with Penfill 30r Chu. Patient felt the following Penfill side effects: anti-insulin antibody increased, hypoglycaemia unawareness. Penfill 30r Chu dosage: Unk, Bid.
Multiple prescriptions taken:
  • Novorapid Chu Flexpen (Unk)
  • Lispro Insulin


Anti-insulin Antibody Increased, Condition Aggravated, Diabetic Ketoacidotic Hyperglycaemic Coma, Hyperglycaemia, Hypoglycaemia, Psychiatric Symptom
Patient was taking Penfill 30r Chu. After Penfill was administered, patient encountered several Penfill side effects: anti-insulin antibody increased, condition aggravated, diabetic ketoacidotic hyperglycaemic coma, hyperglycaemia, hypoglycaemia, psychiatric symptom on Nov 04, 2010 from JAPAN Additional patient health information: Male , 78 years of age, was diagnosed with and. Penfill 30r Chu dosage: Not Reported. Patient was hospitalized.

Altered State Of Consciousness, Epilepsy, Hypoglycaemia, Retrograde Amnesia
Adverse event was reported on Jan 28, 2010 by a Male taking Penfill N Chu (Dosage: Not Reported) was diagnosed with and. Location: JAPAN , 39 years of age, Directly after, patient experienced the unwanted or unexpected Penfill side effects: altered state of consciousness, epilepsy, hypoglycaemia, retrograde amnesia. Patient was hospitalized.

Oedema, Weight Increased
on Jan 25, 2010 Female from JAPAN , 61 years of age, was diagnosed with and was treated with Penfill 30r Chu. Patient felt the following Penfill side effects: oedema, weight increased. Penfill 30r Chu dosage: Unk U, Unk.
Multiple prescriptions taken:
  • Actos (/po)
Patient was hospitalized.

Altered State Of Consciousness, Epilepsy, Hypoglycaemia, Retrograde Amnesia
on Jan 13, 2010 Male from JAPAN , 39 years of age, was diagnosed with and was treated with Penfill N Chu. After Penfill was administered, patient encountered several Penfill side effects: altered state of consciousness, epilepsy, hypoglycaemia, retrograde amnesia. Penfill N Chu dosage: Not Reported. Patient was hospitalized.

Hepatic Function Abnormal
Patient was taking Penfill R Chu. Directly after, patient experienced the unwanted or unexpected Penfill side effects: hepatic function abnormal on Dec 02, 2009 from JAPAN Additional patient health information: Female , 55 years of age, weighting 156.5 lb, was diagnosed with and. Penfill R Chu dosage: Sliding Scale.
Associated medications used:
  • Penfill N Chu (Sliding Scale)
  • Novolin R ((6+6+2+0) Iu, Qd)
  • Novolin N ((0+0+0+5) Iu, Qd)
  • Magmitt (990 Mg, Qd)
  • Alosenn /00476901/ (0.5 G, Qd)
Patient was hospitalized.

Hepatic Function Abnormal
Adverse event was reported on Nov 06, 2009 by a Female taking Penfill R Chu (Dosage: Sliding Scale) was diagnosed with and. Location: JAPAN , 55 years of age, weighting 156.5 lb, Patient felt the following Penfill side effects: hepatic function abnormal.
Multiple prescriptions taken:
  • Penfill N Chu (Sliding Scale)
  • Novolin R ((6+6+2+0) Iu, Qd)
  • Novolin N ((0+0+0+5) Iu, Qd)
  • Magmitt (990 Mg, Qd)
  • Alosenn /00476901/ (0.5 G, Qd)
Patient was hospitalized.

Altered State Of Consciousness, Hypoglycaemic Coma
on Oct 16, 2009 Female from JAPAN , 60 years of age, was diagnosed with and was treated with Penfill 50r Chu. After Penfill was administered, patient encountered several Penfill side effects: altered state of consciousness, hypoglycaemic coma. Penfill 50r Chu dosage: 16 Iu, Qd. Patient was hospitalized.

Altered State Of Consciousness, Hypoglycaemic Coma
on Sep 11, 2009 Female from JAPAN , 60 years of age, was diagnosed with and was treated with Penfill 50r Chu. Directly after, patient experienced the unwanted or unexpected Penfill side effects: altered state of consciousness, hypoglycaemic coma. Penfill 50r Chu dosage: 16 Iu, Qd. Patient was hospitalized.

Hypoglycaemia, Hypoglycaemic Coma, Intentional Overdose, Suicide Attempt
Patient was taking Penfill 30r Chu. Patient felt the following Penfill side effects: hypoglycaemia, hypoglycaemic coma, intentional overdose, suicide attempt on Aug 19, 2009 from JAPAN Additional patient health information: Female , weighting 125.7 lb, was diagnosed with and. Penfill 30r Chu dosage: 10+12+0 Iu, Qd. Patient was hospitalized.

Hypoglycaemia, Suicide Attempt
Adverse event was reported on Jul 30, 2009 by a Male taking Penfill N Chu (Dosage: 13 Iu, Qd) was diagnosed with and. Location: JAPAN , 37 years of age, After Penfill was administered, patient encountered several Penfill side effects: hypoglycaemia, suicide attempt. Patient was hospitalized.

Hypoglycaemia, Suicide Attempt
on Jul 10, 2009 Male from JAPAN , 37 years of age, was diagnosed with and was treated with Penfill N Chu. Directly after, patient experienced the unwanted or unexpected Penfill side effects: hypoglycaemia, suicide attempt. Penfill N Chu dosage: Unk Iu, Unk. Patient was hospitalized.

Blood Glucose Increased, Injection Site Reaction
on May 28, 2009 Male from JAPAN , 50 years of age, weighting 163.1 lb, was diagnosed with and was treated with Penfill R Chu. Patient felt the following Penfill side effects: blood glucose increased, injection site reaction. Penfill R Chu dosage: 4-4-4.
Multiple prescriptions taken:
  • Penfill 30r Chu (14-18 Iu)
  • Lantus
  • Metformin Hydrochloride (500 Mg, Qd)
  • Alotec (5 Mg, Unk)
Patient was hospitalized.

Anti-insulin Antibody, Autoantibody Positive, Bladder Perforation, Blood Glucose Fluctuation
Patient was taking Penfill 30r Chu. After Penfill was administered, patient encountered several Penfill side effects: anti-insulin antibody, autoantibody positive, bladder perforation, blood glucose fluctuation on Mar 19, 2009 from JAPAN Additional patient health information: Female , 58 years of age, was diagnosed with and. Penfill 30r Chu dosage: Unk, Unk. Patient was hospitalized.

Anti-insulin Antibody Increased, Hypoglycaemia
Adverse event was reported on Feb 24, 2009 by a Female taking Penfill R Chu (Dosage: N/A) was diagnosed with and. Location: JAPAN , 70 years of age, weighting 154.3 lb, Directly after, patient experienced the unwanted or unexpected Penfill side effects: anti-insulin antibody increased, hypoglycaemia.
Associated medications used:
  • Penfill 30r Chu
  • Humalog
  • Lantus
Patient was hospitalized.

Anti-insulin Antibody, Hypoglycaemia
on Nov 20, 2008 Male from JAPAN , 68 years of age, was diagnosed with and was treated with Penfill 30r Chu. Patient felt the following Penfill side effects: anti-insulin antibody, hypoglycaemia. Penfill 30r Chu dosage: (20-0-10).
Multiple prescriptions taken:
  • Penfill R Chu (Not Reported)
  • Penfill 10r Chu (Not Reported)
  • Penfill N Chu (Not Reported)
  • Penfill R Chu ((4-4-2))
  • Humalog ((4-4-2))
Patient was hospitalized.

Hypoglycaemic Coma, Intentional Overdose, Suicide Attempt
on Nov 04, 2008 Male from JAPAN , 65 years of age, weighting 130.1 lb, was diagnosed with and was treated with Penfill 50r Chu. After Penfill was administered, patient encountered several Penfill side effects: hypoglycaemic coma, intentional overdose, suicide attempt. Penfill 50r Chu dosage: N/A.
Multiple concurrent drugs taken:
  • Penfill R Chu
  • Insulin
  • Sinlestal (750 Mg, Qd)
  • Penfill 30r Chu


Anorexia Nervosa, Hypoglycaemia
Patient was taking Penfill 30r Chu. Directly after, patient experienced the unwanted or unexpected Penfill side effects: anorexia nervosa, hypoglycaemia on Jun 19, 2008 from JAPAN Additional patient health information: Female , weighting 149.9 lb, was diagnosed with and. Penfill 30r Chu dosage: N/A.
Associated medications used:
  • Novorapid Chu
  • Glufast (30 Mg, Qd)
Patient was hospitalized.

Hepatic Function Abnormal
Adverse event was reported on Jun 16, 2008 by a Female taking Penfill N Chu (Dosage: 8 Iu, Qd) was diagnosed with and. Location: JAPAN , 57 years of age, Patient felt the following Penfill side effects: hepatic function abnormal.
Multiple prescriptions taken:
  • Penfill R Chu (24 Iu, Qd)
  • Humalog (24 U, Qd)
  • Humalog
  • Humacart N
  • Flomox
  • Cefaclor


Blood Glucose Fluctuation, Hypoglycaemia
on Jun 10, 2008 Female from JAPAN , 62 years of age, weighting 114.6 lb, was diagnosed with and was treated with Penfill 30r Chu. After Penfill was administered, patient encountered several Penfill side effects: blood glucose fluctuation, hypoglycaemia. Penfill 30r Chu dosage: 20-0-10 Iu, Qd. Patient was hospitalized.

Anorexia Nervosa, Hypoglycaemia
on Jun 06, 2008 Female from JAPAN , weighting 149.9 lb, was diagnosed with and was treated with Penfill 30r Chu. Directly after, patient experienced the unwanted or unexpected Penfill side effects: anorexia nervosa, hypoglycaemia. Penfill 30r Chu dosage: N/A.
Associated medications used:
  • Novorapid Chu
  • Glufast (30 Mg, Qd)
Patient was hospitalized.

1 of 5 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Penfill Side Effects

    Did You Have a Penfill Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Penfill for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    More About Penfill

    Side Effects reported to FDA: 103

    Penfill safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 27

    Latest Penfill clinical trials

    Penfill Reviews

    No reviews, be a first to report a side effect via side effect reporting form